# FDA 483 - Nexus Pharmaceuticals, LLC - November 22, 2019

Source: https://www.globalkeysolutions.net/records/483/nexus-pharmaceuticals-llc/fa5e6e29-7911-49ca-8869-54063d19d85d

> FDA 483 for Nexus Pharmaceuticals, LLC on November 22, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nexus Pharmaceuticals, LLC
- Inspection Date: 2019-11-22
- Product Type: drugs
- Office Name: Chicago District Office
- Summary: An FDA inspection of Nexus Pharmaceuticals Inc, a control testing laboratory in Lincolnshire, IL, identified deficiencies within its quality control unit. The firm failed to ensure that responsibilities and procedures were in writing and fully followed, particularly concerning the timely and thorough investigation of product quality complaints. Additionally, the complaint handling procedure did not identify the correct responsible party.

## Related Documents

- [483 - 2014-11-05](https://www.globalkeysolutions.net/records/483/nexus-pharmaceuticals-llc/98f2e2a3-d907-4230-9890-b8528ea9abf0)

## Related Officers

- [Vaishali J. Patel](https://www.globalkeysolutions.net/people/vaishali-j-patel/3d515b84-e0fd-4f96-914c-f7f09e2de307)
- [Andrew J. Barrowcliff](https://www.globalkeysolutions.net/people/andrew-j-barrowcliff/5dd49407-9028-4c84-9e86-3f0b6239538e)

Company: https://www.globalkeysolutions.net/companies/nexus-pharmaceuticals-llc/9f6c2dd9-2ee0-4492-bcaf-992ff47330cf

Office: https://www.globalkeysolutions.net/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669